|
GRB2 |
growth factor receptor bound protein 2 |
- Interleukin-15 signaling
- Interleukin-15 signaling
- Signaling by CSF3 (G-CSF)
- Signaling by CSF3 (G-CSF)
- STAT5 activation downstream of FLT3 ITD mutants
- Signaling by FLT3 ITD and TKD mutants
- Signaling by FLT3 ITD and TKD mutants
- Signaling by ALK fusions and activated point mutants
- Signaling by LTK
|
- Pegademase
- 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
|
|
|
HTR1A |
5-hydroxytryptamine receptor 1A |
|
- Eletriptan
- Ziprasidone
- Methysergide
- Cabergoline
- Zolmitriptan
- Dihydroergotamine
- Amitriptyline
- Olanzapine
- Clozapine
- Loxapine
- Pramipexole
- Methylphenidate
- Imipramine
- Chlorpromazine
- Buspirone
- Haloperidol
- Nortriptyline
- Amoxapine
- Propranolol
- Fenfluramine
- Lisuride
- Trazodone
- Sumatriptan
- Ergotamine
- Apomorphine
- Paroxetine
- Trimipramine
- Risperidone
- Alprenolol
- Ondansetron
- Oxymetazoline
- Naratriptan
- Pindolol
- Dopamine
- Ergoloid mesylate
- Doxepin
- Nefazodone
- Desipramine
- Escitalopram
- Pergolide
- Bromocriptine
- Ketamine
- Quetiapine
- Aripiprazole
- Chlorprothixene
- Paliperidone
- Penbutolol
- Yohimbine
- Acepromazine
- Alverine
- Molindone
- Pipotiazine
- Lysergic acid diethylamide
- Dapoxetine
- Bifeprunox
- Flibanserin
- Iloperidone
- Lofexidine
- Lesopitron
- Rotigotine
- MN-305
- LI-301
- Naluzotan
- Cariprazine
- Mianserin
- Pizotifen
- Asenapine
- Xaliproden
- Dotarizine
- Sarizotan
- Repinotan
- Robalzotan
- Vilazodone
- Bopindolol
- Cinitapride
- Lurasidone
- Perospirone
- Cannabidiol
- Vortioxetine
- Brexpiprazole
- Dosulepin
- Pirlindole
- Tianeptine
- Setiptiline
- Dihydroergocornine
- Tetrahydrocannabivarin
- Pardoprunox
- Gilteritinib
- Lecozotan
- Lecozotan
- Tiapride
- Dihydroergocristine
- Medical Cannabis
- 5-methoxy-N,N-dimethyltryptamine
- Nabiximols
- Aripiprazole lauroxil
- SEP-363856
- Serdexmethylphenidate
|
|
|
HULC |
hepatocellular carcinoma up-regulated long non-coding RNA |
|
|
|
|
IL17RD |
interleukin 17 receptor D |
- MAP2K and MAPK activation
|
|
|
|
ITGB3 |
integrin subunit beta 3 |
- Platelet degranulation
- Elastic fibre formation
- PECAM1 interactions
- Molecules associated with elastic fibres
- Integrin cell surface interactions
- Integrin cell surface interactions
- TGF-beta receptor signaling activates SMADs
- Syndecan interactions
- Syndecan interactions
- ECM proteoglycans
- Integrin signaling
- GRB2:SOS provides linkage to MAPK signaling for Integrins
- p130Cas linkage to MAPK signaling for integrins
- VEGFA-VEGFR2 Pathway
- Signal transduction by L1
- MAP2K and MAPK activation
- Signaling by moderate kinase activity BRAF mutants
- Signaling by high-kinase activity BRAF mutants
- Signaling by BRAF and RAF1 fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
|
- Abciximab
- Eptifibatide
- Antithymocyte immunoglobulin (rabbit)
- Levothyroxine
- Tirofiban
- Resveratrol
- Lefradafiban
- LM-609
- Fradafiban
- Ferric maltol
|
- Allograft rejection
- Glanzmann thrombasthenia
|
|
ITK |
IL2 inducible T cell kinase |
- Generation of second messenger molecules
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
|
- Staurosporine
- Pazopanib
- Fostamatinib
- Zanubrutinib
|
|
|
KLB |
klotho beta |
- PI3K Cascade
- PIP3 activates AKT signaling
- betaKlotho-mediated ligand binding
- Constitutive Signaling by Aberrant PI3K in Cancer
- Phospholipase C-mediated cascade; FGFR4
- FRS-mediated FGFR4 signaling
- SHC-mediated cascade:FGFR4
- PI-3K cascade:FGFR4
- Negative regulation of FGFR4 signaling
- RAF/MAP kinase cascade
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
|
|
|
KPNB1 |
karyopherin subunit beta 1 |
- ISG15 antiviral mechanism
- Apoptosis induced DNA fragmentation
- Regulation of cholesterol biosynthesis by SREBP (SREBF)
- Transport of Ribonucleoproteins into the Host Nucleus
- NS1 Mediated Effects on Host Pathways
- Nuclear import of Rev protein
- Nuclear import of Rev protein
- Initiation of Nuclear Envelope (NE) Reformation
- Neutrophil degranulation
- Assembly of the ORC complex at the origin of replication
- Interferon alpha/beta signaling
- Postmitotic nuclear pore complex (NPC) reformation
- Inhibition of nitric oxide production
- SARS-CoV-1 activates/modulates innate immune responses
- Maturation of hRSV A proteins
|
|
|
|
L1CAM |
L1 cell adhesion molecule |
- Basigin interactions
- L1CAM interactions
- L1CAM interactions
- Recycling pathway of L1
- Recycling pathway of L1
- Interaction between L1 and Ankyrins
- Interaction between L1 and Ankyrins
- Signal transduction by L1
|
|
- Syndromic X-linked mental retardation with epilepsy or seizures, including: West syndrome (WS); Partington syndrome (PRTS); Proud syndrome (ACCAG); XMR and epilepsy (XMRE); MRXHF1; XMR OPHN1-related (MRXSO) ; XELBD; XMR, Christianson type (MRXSC); Creatine deficiency syndrome (XL-CDS); Renpenning syndrome (RENS1); Epilepsy and mental retardation limited to females (EFMR); Periventricular nodular heterotopia (PVNH); Hydrocephalus (XLH); XMR, JARID1C related (MRXSJ); Boerjeson-Forssman syndrome (BFLS); CK syndrome (CKS)
- L1 syndrome, including: ; X-linked hydrocephalus; MASA syndrome; X-linked complicated spastic paraplegia type I ; X-linked partial agenesis of corpus callosum
- Hereditary spastic paraplegia (SPG)
|
|
LDHA |
lactate dehydrogenase A |
- Pyruvate metabolism
- Regulation of pyruvate metabolism
|
- NADH
- Etheno-NAD
- Nicotinamide
- Oxamic Acid
- Stiripentol
- Copper
- Artenimol
|
|
|
MFHAS1 |
multifunctional ROCO family signaling regulator 1 |
|
|
|
|
MMP2 |
matrix metallopeptidase 2 |
- Collagen degradation
- Collagen degradation
- Degradation of the extracellular matrix
- Degradation of the extracellular matrix
- Activation of Matrix Metalloproteinases
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- EPH-ephrin mediated repulsion of cells
- Interleukin-4 and Interleukin-13 signaling
- Extra-nuclear estrogen signaling
|
- Marimastat
- Captopril
- SC-74020
- Halofuginone
- AE-941
- Endostatin
- Oleandrin
|
- Choriocarcinoma
- Penile cancer
- Torg-Winchester syndrome
|
|
NCAM1 |
neural cell adhesion molecule 1 |
- ECM proteoglycans
- NCAM signaling for neurite out-growth
- NCAM signaling for neurite out-growth
- NCAM1 interactions
- NCAM1 interactions
- Signal transduction by L1
- RAF/MAP kinase cascade
- Interferon gamma signaling
|
|
|
|
NCK1 |
NCK adaptor protein 1 |
- Downstream signal transduction
- Generation of second messenger molecules
- Regulation of actin dynamics for phagocytic cup formation
- Regulation of actin dynamics for phagocytic cup formation
- Nephrin family interactions
- DCC mediated attractive signaling
- DCC mediated attractive signaling
- Activation of RAC1
- VEGFA-VEGFR2 Pathway
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate WASPs and WAVEs
- RHOU GTPase cycle
- RHOV GTPase cycle
- FCGR3A-mediated phagocytosis
- FCGR3A-mediated phagocytosis
- Potential therapeutics for SARS
- PKR-mediated signaling
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
|
|
|
NCK2 |
NCK adaptor protein 2 |
- Downstream signal transduction
- Nephrin family interactions
- Ephrin signaling
- Activation of RAC1
- VEGFA-VEGFR2 Pathway
- Regulation of cortical dendrite branching
- RHOU GTPase cycle
- RHOV GTPase cycle
|
|
|
|
NECTIN1 |
nectin cell adhesion molecule 1 |
- Adherens junctions interactions
- Nectin/Necl trans heterodimerization
|
|
- Isolated orofacial clefts, including: Cleft lip with or without cleft palate; Cleft palate
|
|
NEDD4 |
NEDD4 E3 ubiquitin protein ligase |
- ISG15 antiviral mechanism
- Downregulation of ERBB4 signaling
- Regulation of PTEN localization
- Regulation of PTEN stability and activity
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
NRG1 |
neuregulin 1 |
- Signaling by ERBB2
- Signaling by ERBB4
- SHC1 events in ERBB2 signaling
- SHC1 events in ERBB2 signaling
- PI3K events in ERBB4 signaling
- SHC1 events in ERBB4 signaling
- Nuclear signaling by ERBB4
- PIP3 activates AKT signaling
- GRB7 events in ERBB2 signaling
- Downregulation of ERBB2:ERBB3 signaling
- GRB2 events in ERBB2 signaling
- PI3K events in ERBB2 signaling
- Constitutive Signaling by Aberrant PI3K in Cancer
- RAF/MAP kinase cascade
- ERBB2 Regulates Cell Motility
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- ERBB2 Activates PTK6 Signaling
- Downregulation of ERBB2 signaling
- Long-term potentiation
- Signaling by ERBB2 KD Mutants
- Signaling by ERBB2 TMD/JMD mutants
|
|
|
|
NRP1 |
neuropilin 1 |
- Neurophilin interactions with VEGF and VEGFR
- Signaling by ROBO receptors
- Sema3A PAK dependent Axon repulsion
- SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
- SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
- CRMPs in Sema3A signaling
- CRMPs in Sema3A signaling
- Signal transduction by L1
- CHL1 interactions
- Attachment and Entry
|
|
|
|
OR51B4 |
olfactory receptor family 51 subfamily B member 4 |
- Expression and translocation of olfactory receptors
|
|
|